Authors: SPALDING A VAITKEVICIUS H DILL S MACKENZIE S SCHMAIER A LOCKETTE W

Citation: A. Spalding et al., MECHANISM OF EPINEPHRINE-INDUCED PLATELET-AGGREGATION, Hypertension, 31(2), 1998, pp. 603-607

Authors: SPALDING A FREEMAN K SCHMAIER A LOCKETTE W

Citation: A. Spalding et al., MECHANISM OF EPINEPHRINE-INDUCED PLATELET-AGGREGATION, The FASEB journal, 10(3), 1996, pp. 3661-3661

Authors: CHIMOWITZ M MANSBACH H SCHMAIER A NICHOLS W GINSBURG D

Citation: M. Chimowitz et al., FACTOR-V MUTATION AND CRYPTOGENIC STROKE IN THE YOUNG, Stroke, 27(1), 1996, pp. 122-122

Authors: CHAO JL SCHMAIER A CHEN LM YANG ZR CHAO L

Citation: Jl. Chao et al., KALLISTATIN, A NOVEL HUMAN TISSUE KALLIKREIN INHIBITOR - LEVELS IN BODY-FLUIDS, BLOOD-CELLS, AND TISSUES IN HEALTH AND DISEASE, The Journal of laboratory and clinical medicine, 127(6), 1996, pp. 612-620

Authors: FREEMAN K FARROW S SCHMAIER A FREEDMAN R SCHORK T LOCKETTE W

Citation: K. Freeman et al., GENETIC-POLYMORPHISM OF THE ALPHA(2)-ADRENERGIC RECEPTOR IS ASSOCIATED WITH INCREASED PLATELET-AGGREGATION, BARORECEPTOR SENSITIVITY, AND SALT EXCRETION IN NORMOTENSIVE HUMANS, American journal of hypertension, 8(9), 1995, pp. 863-869